Pathway Financial Advisers’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Sell
28,624
-379
-1% -$27K 0.61% 62
2025
Q4
$1.79M Sell
29,003
-131
-0.4% -$7.71K 0.52% 70
2025
Q3
$1.71M Sell
29,134
-17
-0.1% -$991 0.5% 70
2025
Q2
$1.7M Sell
29,151
-1,110
-4% -$62.7K 0.55% 65
2025
Q1
$1.5M Buy
30,261
+116
+0.4% +$5.93K 0.52% 66
2024
Q4
$1.35M Sell
30,145
-543
-2% -$25.8K 0.45% 67
2024
Q3
$1.47M Buy
30,688
+2,884
+10% +$139K 0.67% 48
2024
Q2
$1.41M Buy
27,804
+758
+3% +$41.5K 0.51% 67
2024
Q1
$1.47M Buy
27,046
+2,314
+9% +$121K 0.53% 66
2023
Q4
$1.39M Sell
24,732
-193
-0.8% -$10.9K 0.53% 66
2023
Q3
$1.54M Buy
+24,925
New +$1.58M 0.64% 57
2023
Q1
$1.81M Sell
24,456
-1,823
-7% -$141K 0.73% 50
2022
Q4
$1.92M Buy
+26,279
New +$2.08M 0.78% 46

Other funds holding NTR

Pathway Financial Advisers's NTR Position: Q1 2026 in Review

Pathway Financial Advisers reduced its Nutrien (NTR) stake by 1.3% in Q1 2026, selling an estimated $27K and leaving 28,624 shares worth $2.16M. The position accounts for 0.61% of the portfolio, ranked #62.

Pathway Financial Advisers first reported a position in NTR in Q4 2022 and has held it in 13 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Pathway Financial Advisers held 28,624 shares of Nutrien worth $2.16M as of Q1 2026.
  • Pathway Financial Advisers sold 379 Nutrien shares in Q1 2026, an estimated $27K.
  • Nutrien made up 0.61% of Pathway Financial Advisers's portfolio in Q1 2026, its #62 holding.
  • Pathway Financial Advisers first reported a position in Nutrien in Q4 2022 and has held it in 13 quarters since.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Pathway Financial Advisers's 13F filing for Q1 2026, filed 23 Apr 2026.